# Treatment of Severe Adenovirus Infection With HAdV‐B21 in a Young Obese Male With Normal Immunity

**Authors:** Ji Peng, Zhen Wang, Shili Zhong

PMC · DOI: 10.1002/ccr3.71109 · Clinical Case Reports · 2025-10-22

## TL;DR

A healthy obese man developed severe pneumonia from a rare adenovirus and was successfully treated with a combination of therapies.

## Contribution

This case highlights the severity of HAdV-B21 and supports combined antiviral/anti-inflammatory treatment.

## Key findings

- HAdV-B21 can cause life-threatening pneumonia in immunocompetent individuals.
- Treatment with ribavirin, corticosteroids, and prone positioning was effective without needing ECMO.

## Abstract

Adenovirus infections are usually mild, but rare serotypes like “HAdV‐B21” can cause severe pneumonia even in healthy individuals. We report a 32‐year‐old immunocompetent obese male who developed life‐threatening HAdV‐B21 pneumonia (PaO2/FiO2 62 mmHg), requiring mechanical ventilation. Successful treatment included ribavirin, corticosteroids, and prone positioning, avoiding ECMO. This case demonstrates the potential severity of rare adenovirus strains and supports combined antiviral/anti‐inflammatory therapy for such infections.

## Linked entities

- **Chemicals:** ribavirin (PubChem CID 37542)
- **Diseases:** pneumonia (MONDO:0005249), adenovirus infection (MONDO:0043479)

## Full-text entities

- **Diseases:** Adenovirus Infection (MESH:D000257), pneumonia (MESH:D011014), infections (MESH:D007239), inflammatory (MESH:D007249), Obese (MESH:D009765)
- **Chemicals:** ribavirin (MESH:D012254)
- **Species:** Adenoviridae (family) [taxon 10508]

## Full text

_Full body text omitted from this summary view._ Fetch the complete paper as Markdown: https://tomesphere.com/paper/PMC12544705/full.md

## Figures

2 figures with captions in the complete paper: https://tomesphere.com/paper/PMC12544705/full.md

## References

16 references — full list in the complete paper: https://tomesphere.com/paper/PMC12544705/full.md

---
Source: https://tomesphere.com/paper/PMC12544705